Ma keʻano he analike hoʻolālā o α-MSH (melanocyte-stimulating hormone), Melanotan-II (MT-II) hōʻike i nā waiwai like me α-MSH. Hana ia ma ke ʻano he koho ʻole melanocortin receptor agonist, e hōʻike ana i ka hana ma nā melanocortin receptors MC1R, MC3R, MC4R a MC5R.
Ma ke kahua, ʻO Melanotan-II kahi pōʻaiapuni heptapeptide (Ac-Nle-cyclo[Asp-His-DPhe-Arg-Trp-Lys]-NH₂). Hāʻawi kēia ʻano hoʻolālā cyclized i kahi kaulahao peptide pōkole ma mua o ka linear MT-I.
ʻOiai ua hōʻike ʻia nā haʻawina in vitro e hōʻike ana ʻo Melanotan-II i ka ikaika nāwaliwali ma mua o Melanotan-I i ka hoʻoulu ʻana. melanocyte MC1R e hoʻoulu i ka pigmentation, Ua ʻike ʻia ʻo Melanotan-II e loaʻa nā pono kūpono ma nā ʻano ʻē aʻe, ʻoi loa i ka hoʻoponopono ʻana i ka ʻōnaehana kikowaena.
Kaʻina
Ac-{Hiki}-Asp-His-{d-Phe}-Arg-Trp-Lys-NH2, (2→7)-lactam
Helu CAS
121062-08-6
ʻĀpana Molekala
C50H69N15O9
Kaumaha Molekala
1024.18
Research Of Melanotan-II
1.he aha ka melanotan-II
1)ʻIke a me ka hoʻomohala ʻana
ʻO Melanotan-II kahi agonist receptor melanocortin synthetic i hoʻokumu mua ʻia no ka pale ʻana i ka maʻi maʻi ʻili. Eia naʻe, ʻO kona ʻike ʻole ʻia ʻana o ka ʻōnaehana nūnū waena a me nā hopena hoʻoponopono i ka hana moe kolohe ua hoʻonui i kāna mau noi kūpono ma nā ʻano he nui..
2) Nā hopena o ka ʻili
Ma keʻano he analog o α-MSH, Hiki i ka Melanotan-II ke ho'āla i nā melanocytes a hoʻoulu i ka ʻili ʻili. Ma kahi haʻawina makapō hoʻokahi, ʻEkolu mau mea komo i loaʻa i ka saline a i ʻole Melanotan-II ma o ka subcutaneous injection hoʻokahi i kēlā me kēia lā i nā lā pule no ʻelua pule.
Ua hana hou ʻia nā ana ma ka pūnaewele like i ka lā 21. Ua hōʻike ʻia ka loiloi ʻike maka i ka pigmentation maka i nā mea komo ma hope o ka lawelawe ʻana. Hōʻike nā hōʻike e hoʻolaha ʻo Melanotan-II i ka tanning ma o kāna hana ma ke ʻano he agonist ma ka MC1R i nā melanocytes¹.
3)Lapaʻau Erectile Dysfunction
Hiki i ka Melanotan-II ke mālama i ka male erectile male (ED). Ma kahi pūʻulu liʻiliʻi o 10 nā maʻi me psychogenic ED, ka hoʻokomo ʻana o ka peptide subcutaneous (0.025 mg/kg kaumaha kino) ua loiloi ʻia ma o ka nānā ʻana i ka manawa maoli i loko 6 hola: 8 Ua loaʻa i nā kāne ke kūkulu ʻana i ka pono ma ke kino².
Ua hoʻokūpaʻa ʻia kēia mau ʻike ma kahi haʻawina hoʻokele pālua-makapō³.
4)Nā hopena metabolic
Ua hōʻike nā haʻawina holoholona e hoʻopau ʻo Melanotan-II i ka ʻai a hoʻoikaika i ka momona momona. Noiʻi pono kīkēkē i ka PTP1B(Polokina Tyrosine Phospatase 1B) gene (he mea hoʻoponopono maikaʻi ʻole o ka hōʻailona leptin) i loko POMC(Proopiomelanocortin) neurons o nā ʻiole.
Ua ʻoi aku ka ikaika o kēia mau ʻiole mutant i nā ʻinikua intracerebroventricular o leptin a me Melanotan-II (he agonist melanocortin receptor), hōʻike ʻia e like me ka hoʻonui ʻia ʻana o ka ʻai, poho kaumaha, a thermogenic nā pane.
Eia kekahi, ua hoʻonui ʻia ka hōʻike ʻana o ka MC4R receptor i loko o nā ʻiole⁴ kēia hoʻopau genetic.
2.Ka hopena
Melanotan-II, ma ke ʻano he melanocortin receptor agonist koho ʻole, ʻaʻole wale e hōʻike i ka ʻōlelo hoʻohiki no ka hoʻoulu ʻana i ka pigmentation ʻili akā ua loaʻa pū kekahi i ka hoihoi ʻepekema koʻikoʻi no kāna mau hopena koʻikoʻi i waena o ka hoʻoponopono ʻana i ka hana moekolohe., ʻoi loa i ka hoʻomaikaʻi ʻana iā ED.
ʻO kāna mau hopena lapaʻau mua i ka mālama ʻana iā ED ke paipai nei, a me kona pleiotropic Hoʻokumu ka mīkini hana i kahi kumu hoʻohiki no ka hoʻomohala ʻana i nā therapeutics ED hou.
COA
HPLC
MS





